Navigation Links
Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
Date:12/8/2012

, leading to a shortage of normal white and red blood cells and platelets in the blood, which is associated with clotting defects that can cause serious bleeding. Without prompt diagnosis and treatment, APL can be fatal in a matter of hours or days.

Early treatment regimens for APL relied heavily on anthracycline-based chemotherapy with daunorubicin or idarubicin. In the early 1990s, research supported the addition of a non-chemotherapeutic agent, all-trans-retinoic acid (ATRA, a vitamin A derivative developed from ancient Chinese herbal medicine), to standard regimens. ATRA causes cancer cells to develop fully into mature blood cells, which progress through full differentiation and eventually die (unlike leukemia cells that are unable to fully mature). The combination regimen of chemotherapy and ATRA dramatically improved the survival outlook for those with APL and made the disease curable in up to 80 percent of patients. More recently, another natural compound, arsenic trioxide (ATO), was integrated into APL treatment, showing higher efficacy and better tolerability when compared with conventional chemotherapy. Today, as investigators continue to report the success of targeted cancer therapies (best exemplified by imatinib for chronic myeloid leukemia), researchers have questioned whether traditional toxic chemotherapy is still necessary to achieve high cure rates for patients with APL.

To investigate whether a combination of ATO+ATRA could provide the same therapeutic benefit as conventional treatment including chemotherapy, researchers from the Italian-German cooperative teams Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA), Study Alliance Leukemia (SAL) group, and German-Austrian AML Study Group (AMSLG) designed a multicenter, international Phase III trial in which 162 patients with standard-risk APL were divided into two treatment arms. Patients in Arm A received a regimen of ATO+ATRA, while patients in Arm B received the standard
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
2. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
3. Sharp spike in computer-related injuries predicted for medical workers, find studies
4. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
5. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
6. New studies show effects of mammography guideline changes
7. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
8. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
9. Cancer Drug Reduced Relapses in MS Patients: Studies
10. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
11. Studies Show Limits, Promise of Laser Removal of Tattoos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 Mediaplanet today announces the ... a campaign that aims to bring blood health and ... conversation. The stories in this edition go beyond the ... clinical care, hard-hitting advocacy, research and technological strides needed ... the American Cancer Society, approximately every 3 minutes ...
(Date:2/27/2015)... TN (PRWEB) February 27, 2015 The ... Health, has announced a scholarship for rising freshmen undergraduate ... Nashville’s leading periodontist office specializing in many periodontal procedures ... and treatment of gum disease . In honor ... $1,000 college scholarship for eligible rising freshmen undergraduate students. ...
(Date:2/27/2015)... 27, 2015 Insight Accelerator Labs ... advance the development of an in-line urine flow ... is being developed in direct response to current ... accuracy and error margins with potentially grave consequences. ... measurement and provide trending data analysis to signal ...
(Date:2/27/2015)... Mirena IUD lawsuits ( http://www.mirenalawsuit2014.com/ ) ... uterine perforations and other serious harm due to spontaneous ... forward in the multicounty litigation underway in New Jersey’s ... Court records indicate that the proceeding’s 34th Case Management ... convened that same day. (In Re: Mirena Litigation; Case ...
(Date:2/27/2015)... Over 440,000 patients die annually as a ... two jumbo jet airplanes crashing each day. Now more than ... an effort to do all they can to stay safe. ... the 17th U.S. Surgeon General, discusses the importance of safer ... to address safety issues to ensure that all our patients ...
Breaking Medicine News(10 mins):Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 3Health News:Dr. Richard Carmona, the 17th U.S. Surgeon General, and IntelliCentrics Raise Awareness in Mediaplanet’s “Patient Safety” Campaign 2
... News) -- Average annual premiums for employer-sponsored family health coverage ... than $15,000, according to new research from the Kaiser Family ... average, U.S. workers now pay more than $4,000 each year ... in workers, wages, the 2011 employer health benefits survey found. ...
... The Austen BioInnovation Institute in Akron (ABIA), its founding members ... $500,000 award to fund the Accountable Care Community (ACC) initiative, ... today. ACC is a collective effort aiming to create ... the Akron region. The funding is part of ...
... research suggests that the modern day-day-night-night shift pattern for ... potentially carcinogenic as older, more extreme shift patterns. ... risk of cancer, although the biological mechanism responsible for ... paper,s lead author and a doctoral student in the ...
... Brinster of the University of Pennsylvania School of Veterinary ... according to an announcement today from the White House. ... United States government on scientists and engineers. Brinster, ... Penn Vet, is the first veterinarian and the seventh ...
... (HealthDay News) -- Older, overweight women have about the same ... when their leg strength and power was assessed relative to ... of normal weight, a new study has found. The ... likely to become disabled due to the loss of muscle ...
... Mozes HealthDay Reporter , MONDAY, Sept. 26 (HealthDay ... face a higher risk of dying from heart disease than ... findings also showed a slightly increased risk of cardiovascular trouble ... that the results may indicate a link between infertility and ...
Cached Medicine News:Health News:Cost of U.S. Workers' Health Premiums Surged in 2011 2Health News:Cost of U.S. Workers' Health Premiums Surged in 2011 3Health News:Austen BioInnovation Institute's Accountable Care Community initiative gains national support 2Health News:Modern shift work pattern potentially less harmful to health 2Health News:Penn veterinarian Ralph Brinster awarded National Medal of Science 2Health News:Extra Pounds Linked to Weaker Legs in Older Women 2Health News:Childless Men May Face Higher Heart Disease Risk 2Health News:Childless Men May Face Higher Heart Disease Risk 3
(Date:2/27/2015)... Therapeutics, Inc. (NASDAQ: PTCT ) today announced ... fourth quarter and full year ended December 31, 2014. ... PTC. We are now a growing commercial-stage biopharma company, ... rare disease space," stated Stuart W. Peltz, Ph.D., Chief ... bring the first treatment for Duchenne muscular dystrophy to ...
(Date:2/27/2015)... TEL-AVIV, Israel , February 27, 2015 ... Unternehmen baut sein bahnbrechendes Überwachungssystem für kongestive ... weiter aus -   ... Medical Technologies, die ein neuartiges Herzüberwachungssystem für ... gab heute bekannt, dass sie ein Finanzierungsvorhaben ...
(Date:2/27/2015)... -- Bionik Laboratories Corp. (OTC:DWTPD), a Delaware ... Bionik Laboratories, Inc., a Toronto ... accredited investors of units consisting of its common stock ... million. Shares of the Company,s common stock will continue ... symbol "DWTPD" until FINRA,s approval of the ticker "BNKL." ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3
... SAN DIEGO, March 1, 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: ... present at the following investor conferences: Citi 2011 ... 10:00 a.m. Eastern Time at the Hilton New York Hotel ... Health Care Conference on Monday, March 7, 2011 at 4:45 ...
... March 1, 2011 Valeritas, Inc., ... and commercialization of innovative drug delivery solutions, announced ... has cleared the company,s V-Go Disposable Insulin Delivery ... the continuous subcutaneous delivery of insulin in preset ...
Cached Medicine Technology:Optimer Pharmaceuticals to Present at March 2011 Investor Conferences 2Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device for Use with NovoLog® 2Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device for Use with NovoLog® 3
... CMC joint is the most common site for ... the CMC joint without restricting the wrist or ... persons who need to control or reduce subluxation ... perform work and leisure activities without pain. Also ...
... This is an excellent choice to treat ... MCP joint, basal joint arthritis, advanced carpal ... the thumb and wrist. Distal palmar ... flexion and full finger dexterity. Constructed ...
... CTi Wrist OTS is an off-the-shelf wrist orthotic designed ... of 3 pre-set ranges-of-motion (20°,35° and 50°). , ... sprains with TFCC tear-triangular fibrocartilage complex , ... nonunion , Partial tendon rupture , ...
... CTi Wrist Static is a solid, one-piece custom wrist ... stable, neutral position. , ,Indications: , Wrist ... fibrocartilage complex , Coles fracture - distal ... Partial tendon rupture , ORIF - Open ...
Medicine Products: